Bio-Rad Laboratories ( (BIO) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bio-Rad Laboratories’ stock movement is influenced by Wells Fargo’s decision to lower the company’s price target. This adjustment comes in light of updated financial outlooks and macroeconomic conditions impacting growth projections. Despite reporting a strong Q2 revenue of $651.6 million, surpassing expectations due to effective execution and expense management, the stock faces pressure. Key developments include the acquisition of Stilla Technologies and the expansion of their digital PCR offerings.
More about Bio-Rad Laboratories
YTD Price Performance: -23.33%
Average Trading Volume: 354,402
Technical Sentiment Signal: Sell
Current Market Cap: $6.88B
For further insights into BIO stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.